Enteropathogenic Escherichia Coli—A Summary of the Literature
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cholera Transmission: the Host, Pathogen and Bacteriophage Dynamic
REVIEWS Cholera transmission: the host, pathogen and bacteriophage dynamic Eric J. Nelson*, Jason B. Harris‡§, J. Glenn Morris Jr||, Stephen B. Calderwood‡§ and Andrew Camilli* Abstract | Zimbabwe offers the most recent example of the tragedy that befalls a country and its people when cholera strikes. The 2008–2009 outbreak rapidly spread across every province and brought rates of mortality similar to those witnessed as a consequence of cholera infections a hundred years ago. In this Review we highlight the advances that will help to unravel how interactions between the host, the bacterial pathogen and the lytic bacteriophage might propel and quench cholera outbreaks in endemic settings and in emergent epidemic regions such as Zimbabwe. 15 O antigen Diarrhoeal diseases, including cholera, are the leading progenitor O1 El Tor strain . Although the O139 sero- The outermost, repeating cause of morbidity and the second most common cause group caused devastating outbreaks in the 1990s, the El oligosaccharide portion of LPS, of death among children under 5 years of age globally1,2. Tor strain remains the dominant strain globally11,16,17. which makes up the outer It is difficult to gauge the exact morbidity and mortality An extensive body of literature describes the patho- leaflet of the outer membrane of Gram-negative bacteria. of cholera because the surveillance systems in many physiology of cholera. In brief, pathogenic strains har- developing countries are rudimentary, and many coun- bour key virulence factors that include cholera toxin18 Cholera toxin tries are hesitant to report cholera cases to the WHO and toxin co-regulated pilus (TCP)19,20, a self-binding A protein toxin produced by because of the potential negative economic impact pilus that tethers bacterial cells together21, possibly V. -
Current Topics in Microbiology and Immunology
Current Topics in Microbiology and Immunology Volume 431 Series Editors Rafi Ahmed School of Medicine, Rollins Research Center, Emory University, Atlanta, GA, USA Shizuo Akira Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan Klaus Aktories Faculty of Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Baden-Württemberg, Germany Arturo Casadevall W. Harry Feinstone Department of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Richard W. Compans Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA Jorge E. Galan Boyer Ctr. for Molecular Medicine, School of Medicine, Yale University, New Haven, CT, USA Adolfo Garcia-Sastre Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Bernard Malissen Parc Scientifique de Luminy, Centre d‘Immunologie de Marseille-Luminy, Marseille, France Rino Rappuoli GSK Vaccines, Siena, Italy The review series Current Topics in Microbiology and Immunology provides a synthesis of the latest research findings in the areas of molecular immunology, bacteriology and virology. Each timely volume contains a wealth of information on the featured subject. This review series is designed to provide access to up-to-date, often previously unpublished information. 2019 Impact Factor: 3.095., 5-Year Impact Factor: 3.895 2019 Eigenfaktor Score: 0.00081, Article Influence Score: 1.363 2019 Cite Score: 6.0, SNIP: 1.023, h5-Index: 43 More -
E. Coli: Serotypes Other Than O157:H7 Prepared by Zuber Mulla, BA, MSPH DOH, Regional Epidemiologist
E. coli: Serotypes other than O157:H7 Prepared by Zuber Mulla, BA, MSPH DOH, Regional Epidemiologist Escherichia coli (E. coli) is the predominant nonpathogenic facultative flora of the human intestine [1]. However, several strains of E. coli have developed the ability to cause disease in humans. Strains of E. coli that cause gastroenteritis in humans can be grouped into six categories: enteroaggregative (EAEC), enterohemorrhagic (EHEC), enteroinvasive (EIEC), enteropathogenic (EPEC), enterotoxigenic (ETEC), and diffuse adherent (DAEC). Pathogenic E. coli are serotyped on the basis of their O (somatic), H (flagellar), and K (capsular) surface antigen profiles [1]. Each of the six categories listed above has a different pathogenesis and comprises a different set of O:H serotypes [2]. In Florida, gastrointestinal illness caused by E. coli is reportable in two categories: E. coli O157:H7 or E. coli, other. In 1997, 52 cases of E. coli O157:H7 and seven cases of E. coli, other (known serotype), were reported to the Florida Department of Health [3]. Enteroaggregative E. coli (EAEC) - EAEC has been associated with persistent diarrhea (>14 days), especially in developing countries [1]. The diarrhea is usually watery, secretory and not accompanied by fever or vomiting [1]. The incubation period has been estimated to be 20 to 48 hours [2]. Enterohemorrhagic E. coli (EHEC) - While the main EHEC serotype is E. coli O157:H7 (see July 24, 1998, issue of the “Epi Update”), other serotypes such as O111:H8 and O104:H21 are diarrheogenic in humans [2]. EHEC excrete potent toxins called verotoxins or Shiga toxins (so called because of their close resemblance to the Shiga toxin of Shigella dysenteriae 1This group of organisms is often referred to as Shiga toxin-producing E. -
Escherichia Coli
log bio y: O ro p c e i n M A l c Clinical Microbiology: Open a c c i e n s i l s Delmas et al., Clin Microbiol 2015, 4:2 C Access ISSN: 2327-5073 DOI:10.4172/2327-5073.1000195 Commentary Open Access Escherichia coli: The Good, the Bad and the Ugly Julien Delmas*, Guillaume Dalmasso and Richard Bonnet Microbes, Intestine, Inflammation and Host Susceptibility, INSERM U1071, INRA USC2018, Université Clermont Auvergne, Clermont-Ferrand, France *Corresponding author: Julien Delmas, Microbes, Intestine, Inflammation and Host Susceptibility, INSERM U1071, INRA USC2018, Université Clermont Auvergne, Clermont-Ferrand, France, Tel: +334731779; E-mail; [email protected] Received date: March 11, 2015, Accepted date: April 21, 2015, Published date: Aptil 28, 2015 Copyright: © 2015 Delmas J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract The species Escherichia coli comprises non-pathogenic commensal strains that form part of the normal flora of humans and virulent strains responsible for acute infections inside and outside the intestine. In addition to these pathotypes, various strains of E. coli are suspected of promoting the development or exacerbation of chronic diseases of the intestine such as Crohn’s disease and colorectal cancer. Description replicate within both intestinal epithelial cells and macrophages. These properties were used to define a new pathotype of E. coli designated Escherichia coli is a non-sporeforming, facultatively anaerobic adherent-invasive E. -
Vibrio Cholerae O1, O139)
Cholera! (Toxigenic Vibrio cholerae O1, O139) Note: Only toxigenic strains of Vibrio cholerae serogroups O1 and O139 cause epidemics and are reportable as cholera. This guidance is intended for management of patients with toxigenic strains of V. cholerae serogroups O1 and O139 and early management (i.e., before laboratory confirmation is available) of patients with cholera-like illness returning from regions where cholera activity has been reported (e.g., travelers returning from Haiti or the Dominican Republic). For management of non-toxigenic strains of V. cholerae O1 and O139, toxigenic strains of other V. cholerae serogroups (e.g. O75 and O141), and other Vibrio species, refer to the guidance for vibriosis. PROTOCOL CHECKLIST Enter available information into Merlin within 24 hours of notification Review background on disease, case definition, laboratory testing (section 2, 3, and 4) Contact provider (section 5) Confirm diagnosis Obtain available demographic and clinical information Determine what information was provided to the patient Ensure collection and submission of appropriate specimens (section 4) Interview patient(s) (section 5) Review disease facts (section 2) Description of illness Modes of transmission Ask about exposure to relevant risk factors (section 5) Travel to an area affected by cholera Exposure to untreated water sources Exposure to raw shellfish or undercooked seafood Consumption of food imported from an area affected by cholera Pre-existing conditions Identify any similar cases of illness among contacts Determine -
Systemic Infection Induced by Campylobacter Jejuni: Development of a Mouse Model and Elucidation of Molecular Mechanisms Samantha Terhorst Iowa State University
Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2012 Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms Samantha Terhorst Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Microbiology Commons Recommended Citation Terhorst, Samantha, "Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms" (2012). Graduate Theses and Dissertations. 12653. https://lib.dr.iastate.edu/etd/12653 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms by Samantha Ashley Terhorst A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Toxicology Program of Study Committee: Qijing Zhang, Major Professor Byron Brehm-Stecher Paul Plummer Orhan Sahin Iowa State University Ames, Iowa 2012 Copyright © Samantha Ashley Terhorst, 2012. All rights reserved. ii TABLE OF CONTENTS ABSTRACT ..................................................................................................................... -
A Brief History of the Family of Sonja Escherich-Eisenmenger-Weber
A Brief History of the family of Sonja Escherich-Eisenmenger-Weber © Copyright 1990 Ernst Weber, Tryon, North Carolina Part I Pfaundlers, Oetz and Piburg Part II Theodor Eseherich and Child Care in Vienna Part III Sonya Escherich-Eisenmenger, 1895 until 1936 Privately Printed By M.A. DESIGNS Tryon, NC An Introduction to Sonya & Ernst Weber An address by James M. Flack (son-in-law of Sonya Weber) at the Cosmos Club in Washington, D.C. Tuesday, October 14, 1975 on the occasion of the establishment of the Sonya & Ernst Weber Scholarship Fund. Dr. Bugliarello, Friends, Associates and Family of Sonya and Ernst Weber. It is my honor and privilege to speak on behalf of the dose members of the Weber family. Dr. Bugliarello, we are grateful to you and to Polytechnic for establishing the Sonya and Ernst Weber Scholarship Fund. The criterion for the awards - based on excellence and regardless of need is most appropriate. This is consonant with the lives of the Webers. They have searched for the good - for things of real value. And when things of value were discovered, they were able to recognize, cherish, nurture and reward them to assure their continuity and growth. Sonya and Ernst Weber are well known - both nationally and internationally, each in her and his own field. They have each been showered with honors for their achievements and contributions to a better way of life in our time and for the future to come - Ernst in the field of science as a physicist, engineer, educator and administrator; Sonya also in the field of science as a doctor of physical medicine and physical fitness. -
Issue 2, September 2011
Quarterly Newsletter of the Belgian Society for Microbiology Issue no. 2, September 2011 Contents Welcome by the president of BSM Page 1 As indicated in the program, the morning session Membership Page 2 consists of 4 plenary lectures, while in the News from FEMS Page 2 afternoon 2 parallel sessions (bacteriology, BSM Symposium 2011 Page 3 virology) are programmed with time reserved for Theodor Escherich Page 5 short oral communications from selected Report on MRM Symposium Page 7 abstracts. PhD Corner Page 9 Call for contributions Page 10 Besides this, there will be also ample time to Composition of the BSM board Page 10 discuss during the posters session. As such this meeting is also meant as an opportunity to meet microbiology colleagues and to exchange ideas. More details of the symposium, and how to Welcome register, you will find on p 3. Concomitantly with the start of the new academic year, we send you Issue 2 of the E-Newsletter of the We also started with a series of short overviews Belgian Society for Microbiology. Since the first E- on historical data in microbiology (see p 4), and Newsletter, the BSM board was further active in continue with the PhD corner, and report on FEMS several respects. sponsored activities. The BSM Board has further worked on finalizing the BSM was also for the first time host of the FEMS th program of the symposium (Brussels, 16th November Council meeting held in Leuven 16-17 2011), the yearly most important activity of BSM. September, which was attended by 37 delegates (22 different nationalities) representing different This year’s topic is “Live, death and survival of Micro- microbiological societies unified under the organisms” emphasizing that thanks to the umbrella of FEMS, which altogether represent continuous progress in microbiological sciences, more than 30000 European microbiologists (see strategies used by micro-organisms to live and http://www.fems-microbiology.org). -
The Columbian Exchange: a History of Disease, Food, and Ideas
Journal of Economic Perspectives—Volume 24, Number 2—Spring 2010—Pages 163–188 The Columbian Exchange: A History of Disease, Food, and Ideas Nathan Nunn and Nancy Qian hhee CColumbianolumbian ExchangeExchange refersrefers toto thethe exchangeexchange ofof diseases,diseases, ideas,ideas, foodfood ccrops,rops, aandnd populationspopulations betweenbetween thethe NewNew WorldWorld andand thethe OldOld WWorldorld T ffollowingollowing thethe voyagevoyage ttoo tthehe AAmericasmericas bbyy ChristoChristo ppherher CColumbusolumbus inin 1492.1492. TThehe OldOld WWorld—byorld—by wwhichhich wwee mmeanean nnotot jjustust EEurope,urope, bbutut tthehe eentirentire EEasternastern HHemisphere—gainedemisphere—gained fromfrom tthehe CColumbianolumbian EExchangexchange iinn a nnumberumber ooff wways.ays. DDiscov-iscov- eeriesries ooff nnewew ssuppliesupplies ofof metalsmetals areare perhapsperhaps thethe bestbest kknown.nown. BButut thethe OldOld WWorldorld aalsolso ggainedained newnew staplestaple ccrops,rops, ssuchuch asas potatoes,potatoes, sweetsweet potatoes,potatoes, maize,maize, andand cassava.cassava. LessLess ccalorie-intensivealorie-intensive ffoods,oods, suchsuch asas tomatoes,tomatoes, chilichili peppers,peppers, cacao,cacao, peanuts,peanuts, andand pineap-pineap- pplesles wwereere aalsolso iintroduced,ntroduced, andand areare nownow culinaryculinary centerpiecescenterpieces inin manymany OldOld WorldWorld ccountries,ountries, namelynamely IItaly,taly, GGreece,reece, andand otherother MediterraneanMediterranean countriescountries (tomatoes),(tomatoes), -
5Th Theodor Escherich & 2Nd AMICI Joint Symposium
5th Theodor Escherich & 2nd AMICI Joint Symposium 8th - 9th November 2018 Neuer Med Campus, Neue Stiftingtalstraße 2 Medical University of Graz, Austria ABSTRACT BOOK If you do’t like iroes, you’re o the rog plaet (Stewart Brand, adapted) In behalf of the organizing committee of the 5th Theodor Escherich & 2nd AMICI Joint Symposium 2018 we cordially welcome you at the Medical University of Graz. We are very pleased with the high number of renowned national and international scientists oerig the topis iroioe ad aer, iroioe ad utritio, iroioe ad eiroet, egleted eers of the hua iroioe, iroiota odulatio ad the plat iroioe that hae aepted our iitatio to speak. We will have more than 200 guests from Austria and Europe, interested interdisciplinary microbiome research. The new Campus at the Medical University in Graz provides an excellent venue for this event, and we are convinced that the wonderful atmosphere in this building will support personal exchange and discussion amongst young researchers and PIs. We are particularly thankful for the fruitful interaction with the Austrian Microbiome Initiative AMICI, serving as an excellent networking platform for microbiome research – resulting in this joint adventure this year! We are extremely grateful for the generous support from our sponsors and industry partners. We are looking forward to a very fruitful meeting, The local organizing committee Gabriele Berg Gregor Christoph Robert Krause, Christine Moissl- TU Graz Gorkiewicz, MUG Högenauer, MUG MUG Eichinger, MUG www.medunigraz.at/microbiome Sehr geehrte Damen und Herren, liebe Kolleginnen und Kollegen! Bakterien, Viren, Archaen, Parasiten und Pilze – unseren Körper teilen wir mit Billionen Bakterien, die Mundhöhle, Haut und Darm besiedeln. -
Shigella and Escherichia Coli at the Crossroads: Machiavellian Masqueraders Or Taxonomic Treachery?
J. Med. Microbiol. Ð Vol. 49 2000), 583±585 # 2000 The Pathological Society of Great Britain and Ireland ISSN 0022-2615 EDITORIAL Shigella and Escherichia coli at the crossroads: machiavellian masqueraders or taxonomic treachery? Shigellae cause an estimated 150 million cases and genera. One authority has even proposed that entero- 600 000 deaths annually, and can cause disease after haemorrhagic E. coli EHEC) such as E. coli O157:H7 ingestion of as few as 10 bacterial cells [1]. They are are essentially `Shigella in a cloak of E. coli antigens' spread by the faecal±oral route, with food, water, [7]. fomites, insects especially ¯ies) and direct person-to- person contact. S. dysenteriae causes brisk and deadly Shigella-like strains of E. coli that cause an invasive, epidemics, particularly in the developing world; S. dysenteric diarrhoeal illness were ®rst described in ¯exneri and S. sonnei account for the endemic form of 1971, over a decade before the appearance in 1982 of the disease, particularly in industrialised nations; S. the new EHEC strains that launched the current wave boydii is rarely encountered [1, 2]. of interest in the E. coli±Shigella connection [8]. Termed `enteroinvasive E. coli' EIEC), these strains, Shigellosis is a locally invasive colitis in which bacteria like shigellae, were able to invade and proliferate invade and proliferate within colonocytes and mucosal within intestinal epithelial cells, eventually causing cell macrophages, trigger apoptosis of macrophages and death [4, 8]. EIEC share with shigellae a c. 140-MDa spread through the mucosa from cell to cell [1]. plasmid pINV) that encodes several outer-membrane Cytokines produced by epithelial cells and macro- proteins involved in invasion of host cells [4, 8]. -
Enteric Infections Due to Campylobacter, Yersinia, Salmonella, and Shigella*
Bulletin of the World Health Organization, 58 (4): 519-537 (1980) Enteric infections due to Campylobacter, Yersinia, Salmonella, and Shigella* WHO SCIENTIFIC WORKING GROUP1 This report reviews the available information on the clinical features, pathogenesis, bacteriology, and epidemiology ofCampylobacter jejuni and Yersinia enterocolitica, both of which have recently been recognized as important causes of enteric infection. In the fields of salmonellosis and shigellosis, important new epidemiological and relatedfindings that have implications for the control of these infections are described. Priority research activities in each ofthese areas are outlined. Of the organisms discussed in this article, Campylobacter jejuni and Yersinia entero- colitica have only recently been recognized as important causes of enteric infection, and accordingly the available knowledge on these pathogens is reviewed in full. In the better- known fields of salmonellosis (including typhoid fever) and shigellosis, the review is limited to new and important information that has implications for their control.! REVIEW OF RECENT KNOWLEDGE Campylobacterjejuni In the last few years, C.jejuni (previously called 'related vibrios') has emerged as an important cause of acute diarrhoeal disease. Although this organism was suspected of being a cause ofacute enteritis in man as early as 1954, it was not until 1972, in Belgium, that it was first shown to be a relatively common cause of diarrhoea. Since then, workers in Australia, Canada, Netherlands, Sweden, United Kingdom, and the United States of America have reported its isolation from 5-14% of diarrhoea cases and less than 1 % of asymptomatic persons. Most of the information given below is based on conclusions drawn from these studies in developed countries.